EUPRAXIA PHARMACEUTICALS INC.

Developing targeted, extended-release therapies for GI and musculoskeletal diseases.

EPRX | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 201-2067 CADBORO BAY RD., VICTORIA
Website:: https://eupraxiapharma.com/home/default.aspx
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Eupraxia Pharmaceuticals Inc. is a clinical-stage biotechnology company developing targeted therapies through its proprietary Diffusphere™ drug delivery platform. This extended-release technology is engineered to deliver medication precisely to the site of disease, aiming to maximize efficacy and duration while minimizing systemic side effects. The company's clinical pipeline is focused on high-need indications in gastrointestinal and musculoskeletal diseases. Its lead candidate, EP-104GI, is in development for the treatment of Eosinophilic Esophagitis (EoE), with other programs targeting joint pain and related disorders. Eupraxia's patient-centric approach seeks to improve treatment outcomes by providing long-acting, localized therapies for conditions where current standards of care are insufficient.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all EUPRAXIA PHARMACEUTICALS INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for EUPRAXIA PHARMACEUTICALS INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for EUPRAXIA PHARMACEUTICALS INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

	Company	Country	Ticker
$AMARIN CORP PLC\UK Logo$	AMARIN CORP PLC\UK Develops prescription therapies like Vascepa® to reduce cardiovascular risk for patients.	United States of America	AMRN
	AMGEN INC Biotech pioneer developing innovative human therapeutics for the world's toughest diseases.	United States of America	AMGN
	Amicogen, Inc. Biotech firm using enzyme tech for pharma, healthcare, and bioprocess CDMO services.	South Korea	092040
	AMICUS THERAPEUTICS, INC. Develops advanced therapies for rare lysosomal storage disorders.	United States of America	FOLD
	AMINOLOGICS CO.,LTD. Manufactures high-purity chiral amino acids & APIs for pharma, chemical, and food industries.	South Korea	074430
	Amneal Pharmaceuticals, Inc. Develops & commercializes essential medicines: generics, injectables & specialty drugs.	United States of America	AMRX
	Amphastar Pharmaceuticals, Inc. Develops and manufactures complex injectable, intranasal, and inhalation pharmaceutical products.	United States of America	AMPH
	Amylyx Pharmaceuticals, Inc. Developing novel therapies for neurodegenerative diseases like ALS and Wolfram syndrome.	United States of America	AMLX
	AN2 Therapeutics, Inc. Developing novel small molecule drugs for infectious diseases and oncology using boron chemistry.	United States of America	ANTX
	Ananda Pharma Plc Develops approved cannabinoid medicines for pain, epilepsy, and heart failure.	United Kingdom	ANAN